These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25660320)

  • 1. GH therapy in transition age: state of the art and future perspectives.
    Cappa M; Caruso M; Saggese G; Salerno MC; Tonini G
    Minerva Endocrinol; 2015 Mar; 40(1):23-35. PubMed ID: 25660320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is GH therapy useful to preserve bone mass in transition-phase patients with GH deficiency?
    Aimaretti G; Corneli G; Rovere S; Croce CG; Ghigo E; Procopio M
    J Endocrinol Invest; 2005; 28(10 Suppl):28-32. PubMed ID: 16550719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency.
    Juul A; Bernasconi S; Clayton PE; Kiess W; DeMuinck-Keizer Schrama S;
    Horm Res; 2002; 58(5):233-41. PubMed ID: 12401943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in BMI and management of patients with childhood onset growth hormone deficiency in the transition phase.
    Bazarra-Castro MÁ; Sievers C; Schwarz HP; Pozza SB; Stalla GK
    Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):507-10. PubMed ID: 23070828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.
    Feinberg MS; Scheinowitz M; Laron Z
    Am Heart J; 2003 Mar; 145(3):549-53. PubMed ID: 12660681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of puberty in growth hormone deficient children.
    Saggese G; Federico G; Barsanti S
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():329-34. PubMed ID: 10698597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuation of growth hormone (GH) treatment during the transition phase is an important factor determining the phenotype of young adults with nonidiopathic childhood-onset GH deficiency.
    Kołtowska-Häggström M; Geffner ME; Jönsson P; Monson JP; Abs R; Hána V; Höybye C; Wollmann HA
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2646-54. PubMed ID: 20335451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic benefits of growth hormone therapy in idiopathic short stature.
    Dahlgren J
    Horm Res Paediatr; 2011; 76 Suppl 3():56-8. PubMed ID: 21912170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lifetime of growth hormone deficiency: a US pediatric perspective.
    Saenger P
    J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1337-42. PubMed ID: 11202206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency.
    Boot AM; van der Sluis IM; Krenning EP; de Muinck Keizer-Schrama SM
    Horm Res; 2009; 71(6):364-71. PubMed ID: 19506395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition care of patients with growth hormone deficiency from pediatric endocrinologists to adult endocrinologists.
    Chamberlain Shea H; Levy RA
    Endocr Pract; 2012; 18(2):256-68. PubMed ID: 22068249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients.
    Attanasio AF; Shavrikova E; Blum WF; Cromer M; Child CJ; Paskova M; Lebl J; Chipman JJ; Shalet SM;
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4857-62. PubMed ID: 15472176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study.
    Koranyi J; Svensson J; Götherström G; Sunnerhagen KS; Bengtsson B; Johannsson G
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4693-9. PubMed ID: 11600527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial.
    Mauras N; Pescovitz OH; Allada V; Messig M; Wajnrajch MP; Lippe B;
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3946-55. PubMed ID: 15855257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.